Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hoon Jin

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Investigational New Drugs|November 1, 2013
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutantsJae-Sik Shin, Seung-Woo Hong, Jai-Hee Moon, et al.
Cell Death and Differentiation|November 5, 2023
Targeting isoforms of RON kinase (MST1R) drives antitumor efficacyJoseph Kim, Dong-In Koh, Minki Lee, et al.
Oncotarget|August 29, 2015
A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancerJai-Hee Moon, Jae-Sik Shin, Seung-Woo Hong, et al.
Molecular Cancer Therapeutics|September 10, 2015
Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor ActivityJae-Cheol Jo, Eun Kyoung Choi, Jae-Sik Shin, et al.
Investigational New Drugs|May 29, 2020
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cellsSeung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, et al.
British Journal of Cancer|April 5, 2019
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutationsJai-Hee Moon, Seung-Woo Hong, Jeong Eun Kim, et al.
Anticancer Research|March 29, 2022
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal CancerJun Ki Hong, DO Yeon Kim, Jae-Sik Shin, et al.
Molecular Medicine Reports|September 8, 2016
SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cellsEun Kyoung Choi, Seung-Mi Kim, Seung-Woo Hong, et al.
Biochemical and Biophysical Research Communications|May 25, 2020
Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLCDong Min Kim, Mi Jin Kim, Jai-Hee Moon, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Investigational New Drugs|November 1, 2013
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutantsJae-Sik Shin, Seung-Woo Hong, Jai-Hee Moon, et al.
Cell Death and Differentiation|November 5, 2023
Targeting isoforms of RON kinase (MST1R) drives antitumor efficacyJoseph Kim, Dong-In Koh, Minki Lee, et al.
Oncotarget|August 29, 2015
A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancerJai-Hee Moon, Jae-Sik Shin, Seung-Woo Hong, et al.
Molecular Cancer Therapeutics|September 10, 2015
Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor ActivityJae-Cheol Jo, Eun Kyoung Choi, Jae-Sik Shin, et al.
Investigational New Drugs|May 29, 2020
Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cellsSeung-Woo Hong, Jae-Sik Shin, Jai-Hee Moon, et al.
British Journal of Cancer|April 5, 2019
Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutationsJai-Hee Moon, Seung-Woo Hong, Jeong Eun Kim, et al.
Anticancer Research|March 29, 2022
CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal CancerJun Ki Hong, DO Yeon Kim, Jae-Sik Shin, et al.
Molecular Medicine Reports|September 8, 2016
SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cellsEun Kyoung Choi, Seung-Mi Kim, Seung-Woo Hong, et al.
Biochemical and Biophysical Research Communications|May 25, 2020
Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLCDong Min Kim, Mi Jin Kim, Jai-Hee Moon, et al.
Pageof 11